Stablecoin Development Corporation (SDEV)
NYSEAMERICAN: SDEV · Real-Time Price · USD
1.260
-0.050 (-3.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Stablecoin Development Revenue
Stablecoin Development had revenue of $-521.00K in the quarter ending December 31, 2025.
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
33.55M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 449.71B |
| Johnson & Johnson | 96.36B |
| Eli Lilly and Company | 65.18B |
| AbbVie | 61.16B |
| TELA Bio | 80.28M |
| Palatin Technologies | 8.96M |
| Evaxion | 7.53M |
| CervoMed | 4.01M |
SDEV News
- 22 days ago - Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV” - GlobeNewsWire
- 5 weeks ago - NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Benzinga
- 5 weeks ago - NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - GlobeNewsWire
- 6 weeks ago - Stablecoin Development Transcript: EGM 2026 - Transcripts
- 6 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 7 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 8 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 9 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire